Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | 6 | $0 | $0 | 2023-10-05 |
| Baker Brothers Life Sciences LP | Director, 10% Owner | 14 | $1.46M | $0 | 2023-08-17 |
| Smith Sean Michael | Principal Accounting Officer | 11 | $0 | $4.4K | 2023-08-11 |
| Lavelle Erin | Director | 2 | $0 | $0 | 2023-06-08 |
| Noonberg Sarah B. | Director | 5 | $0 | $0 | 2023-06-08 |
| Babler Martin | Director | 4 | $0 | $0 | 2023-06-08 |
| PALEKAR ROHAN | Director | 3 | $0 | $0 | 2023-06-08 |
| SIMPSON TODD E | Director | 5 | $0 | $0 | 2023-06-08 |
| Patel Priti | Other | 14 | $0 | $18.0K | 2023-04-03 |
| Cochener Donna | General Counsel, SVP Legal | 2 | $0 | $0 | 2022-08-02 |
| Walkey Carl | Senior Vice President | 30 | $0 | $425.6K | 2022-08-02 |
| DRACHMAN JONATHAN G | See Remarks | 19 | $3.19M | $0 | 2022-08-02 |
| BAKER FELIX | Director | 2 | $0 | $0 | 2022-05-12 |
| Ho Robert | Chief Financial Officer | 8 | $0 | $71.5K | 2022-02-01 |
| Vance Holly | General Counsel | 2 | $0 | $0 | 2021-08-03 |
| Lavelle Erin M. | Director | 2 | $0 | $0 | 2021-05-11 |
| Williams Lewis T | Director | 3 | $0 | $0 | 2021-05-11 |
| BAKER JULIAN | Director | 4 | $6.47M | $0 | 2020-07-07 |
| Nolan Sean P. | Director | 2 | $0 | $0 | 2020-05-05 |
| Green Jeremy | 10% Owner | 13 | $2.01M | $220.1K | 2020-04-02 |
| 667, L.P. | Director | 6 | $25.35M | $0 | 2019-12-20 |
| Lieu Hsiao | Executive VP, Clinical Dev. | 2 | $0 | $0 | 2012-03-30 |
| Evans Daron | Chief Financial Officer | 2 | $0 | $0 | 2012-03-30 |
| Kazam Joshua A | President & CEO | 2 | $0 | $0 | 2012-03-30 |
| BREWER RICHARD B | Executive Chairman | 2 | $0 | $0 | 2012-03-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | X Exercise deriv | 2023-10-05 | 2023-10-10 | 535,601 | — | $0 | 1,521,176 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | X Exercise deriv | 2023-10-05 | 2023-10-10 | 57,049 | — | $0 | 182,775 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | X Exercise | 2023-10-05 | 2023-10-10 | 57,049 | — | $0 | 155,874 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | X Exercise | 2023-10-05 | 2023-10-10 | 535,601 | — | $0 | 1,658,190 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-17 | 2023-08-17 | 7,676 | $0.69 | $5.3K | 489,092 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-17 | 2023-08-17 | 93,091 | $0.69 | $64.2K | 5,551,815 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-17 | 2023-08-17 | 5,041 | $0.69 | $3.5K | 494,133 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-17 | 2023-08-17 | 61,134 | $0.69 | $42.2K | 5,612,949 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-16 | 2023-08-17 | 366 | $0.68 | $249 | 481,416 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-16 | 2023-08-17 | 207,676 | $0.68 | $141.2K | 5,454,290 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-16 | 2023-08-17 | 17,124 | $0.68 | $11.6K | 481,050 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-16 | 2023-08-17 | 4,434 | $0.68 | $3.0K | 5,458,724 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-15 | 2023-08-17 | 358 | $0.67 | $240 | 463,926 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-15 | 2023-08-17 | 1,740,581 | $0.63 | $1.10M | 5,242,272 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-15 | 2023-08-17 | 143,519 | $0.63 | $90.4K | 463,568 | SEC↗ |
| Baker Brothers Life Sciences L | Director, 10% Owner | P Buy | 2023-08-15 | 2023-08-17 | 4,342 | $0.67 | $2.9K | 5,246,614 | SEC↗ |
| Smith Sean Michael | Interim CFO, Prin Acct Off | S Sale | 2023-08-11 | 2023-08-14 | 1,323 | $0.62 | $820 | 21,637 | SEC↗ |
| Smith Sean Michael | Interim CFO, Prin Acct Off | M Exercise deriv | 2023-08-10 | 2023-08-14 | 5,000 | — | $0 | 0 | SEC↗ |
| Smith Sean Michael | Interim CFO, Prin Acct Off | M Exercise | 2023-08-10 | 2023-08-14 | 5,000 | — | $0 | 22,960 | SEC↗ |
| Babler Martin | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lavelle Erin | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PALEKAR ROHAN | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SIMPSON TODD E | Director | A Award deriv | 2023-06-08 | 2023-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Baker Brothers Life Sciences L | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Baker Brothers Life Sciences L | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Patel Priti | Other | S Sale | 2023-04-03 | 2023-04-04 | 3,769 | $0.69 | $2.6K | 37,313 | SEC↗ |
| Patel Priti | Other | M Exercise deriv | 2023-03-31 | 2023-04-04 | 10,000 | — | $0 | 0 | SEC↗ |
| Patel Priti | Other | M Exercise | 2023-03-31 | 2023-04-04 | 10,000 | — | $0 | 41,082 | SEC↗ |
| Patel Priti | Chief Medical Officer | S Sale | 2023-02-02 | 2023-02-03 | 14,380 | $0.60 | $8.6K | 31,082 | SEC↗ |
| Smith Sean Michael | Principal Accounting Officer | S Sale | 2023-02-02 | 2023-02-03 | 3,316 | $0.60 | $2.0K | 15,960 | SEC↗ |
| Patel Priti | Chief Medical Officer | M Exercise deriv | 2023-02-01 | 2023-02-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Smith Sean Michael | Principal Accounting Officer | M Exercise deriv | 2023-02-01 | 2023-02-03 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Patel Priti | Chief Medical Officer | M Exercise | 2023-02-01 | 2023-02-03 | 35,000 | — | $0 | 45,462 | SEC↗ |
| Smith Sean Michael | Principal Accounting Officer | M Exercise | 2023-02-01 | 2023-02-03 | 12,500 | — | $0 | 19,276 | SEC↗ |
| Smith Sean Michael | Principal Accounting Officer | M Exercise deriv | 2022-08-10 | 2022-08-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Smith Sean Michael | Principal Accounting Officer | M Exercise | 2022-08-10 | 2022-08-12 | 5,000 | — | $0 | 8,431 | SEC↗ |
| Smith Sean Michael | Principal Accounting Officer | S Sale | 2022-08-10 | 2022-08-12 | 1,655 | $0.99 | $1.6K | 6,776 | SEC↗ |
| Cochener Donna | General Counsel, SVP Legal | A Award deriv | 2022-08-02 | 2022-08-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | A Award deriv | 2022-08-02 | 2022-08-04 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Patel Priti | Chief Medical Officer | A Award deriv | 2022-08-02 | 2022-08-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Smith Sean Michael | Principal Accounting Officer | A Award deriv | 2022-08-02 | 2022-08-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Walkey Carl | Senior Vice President | A Award deriv | 2022-08-02 | 2022-08-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| BAKER FELIX | Director | A Award deriv | 2022-05-12 | 2022-05-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Babler Martin | Director | A Award deriv | 2022-05-12 | 2022-05-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lavelle Erin | Director | A Award deriv | 2022-05-12 | 2022-05-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2022-05-12 | 2022-05-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PALEKAR ROHAN | Director | A Award deriv | 2022-05-12 | 2022-05-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SIMPSON TODD E | Director | A Award deriv | 2022-05-12 | 2022-05-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Patel Priti | Chief Medical Officer | S Sale | 2022-05-02 | 2022-05-03 | 5,538 | $1.22 | $6.8K | 6,462 | SEC↗ |
| Patel Priti | Chief Medical Officer | M Exercise deriv | 2022-04-30 | 2022-05-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Patel Priti | Chief Medical Officer | M Exercise | 2022-04-30 | 2022-05-03 | 10,000 | — | $0 | 12,000 | SEC↗ |
| Cochener Donna | General Counsel, SVP Legal | A Award deriv | 2022-03-14 | 2022-03-15 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Smith Sean Michael | Principal Accounting Officer | A Award deriv | 2022-03-02 | 2022-03-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| PALEKAR ROHAN | Director | A Award deriv | 2022-03-02 | 2022-03-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Ho Robert | Chief Financial Officer | A Award deriv | 2022-02-01 | 2022-02-02 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Patel Priti | Chief Medical Officer | A Award deriv | 2022-02-01 | 2022-02-02 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Walkey Carl | Senior Vice President | A Award deriv | 2022-02-01 | 2022-02-02 | 55,000 | — | $0 | 55,000 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | P Buy | 2021-08-25 | 2021-08-26 | 25,000 | $6.45 | $161.3K | 25,000 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | P Buy | 2021-08-25 | 2021-08-26 | 25,000 | $6.45 | $161.3K | 25,000 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | P Buy | 2021-08-24 | 2021-08-26 | 100,000 | $6.11 | $611.0K | 2,348,686 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | A Award deriv | 2021-08-03 | 2021-08-05 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Ho Robert | Chief Financial Officer | A Award deriv | 2021-08-03 | 2021-08-05 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Patel Priti | Chief Medical Officer | A Award deriv | 2021-08-03 | 2021-08-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Vance Holly | General Counsel | A Award deriv | 2021-08-03 | 2021-08-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Walkey Carl | Senior Vice President | A Award deriv | 2021-08-03 | 2021-08-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-06-16 | 2021-06-17 | 600 | $10.19 | $6.1K | 1,352,489 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-06-09 | 2021-06-11 | 650 | $10.82 | $7.0K | 1,353,089 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-06-08 | 2021-06-09 | 600 | $11.00 | $6.6K | 1,353,739 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | P Buy | 2021-06-04 | 2021-06-07 | 10,000 | $9.61 | $96.1K | 2,248,686 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-06-04 | 2021-06-07 | 600 | $10.00 | $6.0K | 1,354,339 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | P Buy | 2021-06-03 | 2021-06-07 | 40,000 | $9.48 | $379.2K | 2,238,686 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-05-26 | 2021-05-26 | 600 | $10.00 | $6.0K | 1,354,939 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-05-19 | 2021-05-21 | 600 | $10.63 | $6.4K | 1,355,539 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-05-12 | 2021-05-12 | 1,200 | $11.09 | $13.3K | 1,354,762 | SEC↗ |
| BAKER FELIX | Director | A Award deriv | 2021-05-11 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Babler Martin | Director | A Award deriv | 2021-05-11 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lavelle Erin M. | Director | A Award deriv | 2021-05-11 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2021-05-11 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SIMPSON TODD E | Director | A Award deriv | 2021-05-11 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Williams Lewis T | Director | A Award deriv | 2021-05-11 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-05-05 | 2021-05-06 | 1,200 | $11.30 | $13.6K | 1,355,962 | SEC↗ |
| Patel Priti | Chief Medical Officer | A Award deriv | 2021-04-30 | 2021-05-04 | 475,000 | — | $0 | 475,000 | SEC↗ |
| Patel Priti | Chief Medical Officer | A Award deriv | 2021-04-30 | 2021-05-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-04-28 | 2021-04-30 | 2,400 | $12.58 | $30.2K | 1,357,162 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-04-26 | 2021-04-27 | 600 | $13.00 | $7.8K | 1,359,562 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-04-21 | 2021-04-22 | 1,800 | $11.98 | $21.6K | 1,360,162 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-04-14 | 2021-04-16 | 1,800 | $12.22 | $22.0K | 1,361,962 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-04-07 | 2021-04-08 | 1,800 | $12.02 | $21.6K | 1,363,762 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-04-05 | 2021-04-06 | 600 | $13.00 | $7.8K | 1,365,562 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-03-31 | 2021-04-02 | 1,800 | $11.96 | $21.5K | 1,366,162 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-03-24 | 2021-03-24 | 1,800 | $11.95 | $21.5K | 1,367,962 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-03-22 | 2021-03-24 | 600 | $12.00 | $7.2K | 1,369,762 | SEC↗ |
| Ho Robert | Chief Financial Officer | S Sale | 2021-03-17 | 2021-03-18 | 6,497 | $11.01 | $71.5K | 21,503 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-03-17 | 2021-03-18 | 1,200 | $11.36 | $13.6K | 1,370,362 | SEC↗ |
| Ho Robert | Chief Financial Officer | M Exercise deriv | 2021-03-16 | 2021-03-18 | 25,000 | — | $0 | 50,000 | SEC↗ |
| Ho Robert | Chief Financial Officer | M Exercise | 2021-03-16 | 2021-03-18 | 25,000 | — | $0 | 28,000 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-03-10 | 2021-03-11 | 1,800 | $11.97 | $21.5K | 1,371,562 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-03-03 | 2021-03-04 | 1,800 | $11.87 | $21.4K | 1,373,362 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-02-25 | 2021-02-25 | 600 | $13.00 | $7.8K | 1,375,162 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-02-24 | 2021-02-25 | 1,800 | $12.14 | $21.9K | 1,375,762 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-02-17 | 2021-02-18 | 2,400 | $12.70 | $30.5K | 1,377,562 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-02-10 | 2021-02-12 | 3,000 | $14.20 | $42.6K | 1,379,962 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-02-05 | 2021-02-09 | 600 | $14.00 | $8.4K | 1,382,962 | SEC↗ |
| Walkey Carl | Senior Vice President | S Sale | 2021-02-03 | 2021-02-05 | 2,400 | $13.23 | $31.8K | 1,383,562 | SEC↗ |
| Walkey Carl | Senior Vice President | A Award deriv | 2021-01-30 | 2021-02-02 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Vance Holly | General Counsel | A Award deriv | 2020-10-19 | 2020-10-20 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Babler Martin | Director | A Award deriv | 2020-09-08 | 2020-09-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | A Award deriv | 2020-08-10 | 2020-08-12 | 420,000 | — | $0 | 420,000 | SEC↗ |
| Ho Robert | Chief Financial Officer | A Award deriv | 2020-08-10 | 2020-08-12 | 90,000 | — | $0 | 90,000 | SEC↗ |
| BAKER JULIAN | Director | P Buy deriv | 2020-07-07 | 2020-12-23 | 38,974 | — | $0 | 1,199,122 | SEC↗ |
| BAKER JULIAN | Director | P Buy deriv | 2020-07-07 | 2020-12-23 | 518,555 | — | $0 | 10,283,888 | SEC↗ |
| BAKER JULIAN | Director | P Buy | 2020-07-07 | 2020-12-23 | 29,640 | $15.25 | $452.0K | 320,049 | SEC↗ |
| BAKER JULIAN | Director | P Buy | 2020-07-07 | 2020-12-23 | 394,360 | $15.25 | $6.01M | 3,501,691 | SEC↗ |
| Lavelle Erin M. | Director | A Award deriv | 2020-06-01 | 2020-06-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Nolan Sean P. | Director | A Award deriv | 2020-05-05 | 2020-05-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2020-05-05 | 2020-05-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SIMPSON TODD E | Director | A Award deriv | 2020-05-05 | 2020-05-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Williams Lewis T | Director | A Award deriv | 2020-05-05 | 2020-05-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | Director | A Award deriv | 2020-05-05 | 2020-05-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Green Jeremy | 10% Owner | S Sale | 2020-04-02 | 2020-04-06 | 9,734 | $11.30 | $110.0K | 4,041,311 | SEC↗ |
| Green Jeremy | 10% Owner | P Buy | 2020-04-02 | 2020-04-06 | 38,300 | $11.36 | $435.1K | 4,050,045 | SEC↗ |
| Green Jeremy | 10% Owner | P Buy | 2020-04-02 | 2020-04-06 | 1,000 | $11.85 | $11.8K | 4,051,045 | SEC↗ |
| Green Jeremy | 10% Owner | S Sale | 2020-04-02 | 2020-04-06 | 100 | $11.82 | $1.2K | 4,041,211 | SEC↗ |
| Green Jeremy | 10% Owner | P Buy | 2020-04-01 | 2020-04-06 | 9,000 | $11.65 | $104.8K | 4,021,579 | SEC↗ |
| Green Jeremy | 10% Owner | P Buy | 2020-04-01 | 2020-04-06 | 33,500 | $10.95 | $366.8K | 4,012,579 | SEC↗ |
| Green Jeremy | 10% Owner | S Sale | 2020-04-01 | 2020-04-06 | 9,634 | $11.06 | $106.6K | 4,011,945 | SEC↗ |
| Green Jeremy | 10% Owner | S Sale | 2020-04-01 | 2020-04-06 | 200 | $11.87 | $2.4K | 4,011,745 | SEC↗ |
| Green Jeremy | 10% Owner | P Buy | 2020-03-31 | 2020-04-06 | 22,500 | $10.18 | $229.1K | 3,971,579 | SEC↗ |
| Green Jeremy | 10% Owner | P Buy | 2020-03-31 | 2020-04-06 | 7,500 | $10.71 | $80.3K | 3,979,079 | SEC↗ |
| Green Jeremy | 10% Owner | P Buy | 2020-03-30 | 2020-04-06 | 29,800 | $9.91 | $295.3K | 3,946,379 | SEC↗ |
| Green Jeremy | 10% Owner | P Buy | 2020-03-30 | 2020-04-06 | 2,700 | $10.27 | $27.7K | 3,949,079 | SEC↗ |
| Green Jeremy | 10% Owner | P Buy | 2020-03-27 | 2020-04-06 | 50,000 | $9.21 | $460.5K | 3,916,579 | SEC↗ |
| Ho Robert | Chief Financial Officer | A Award deriv | 2020-03-16 | 2020-03-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Ho Robert | Chief Financial Officer | A Award deriv | 2020-03-16 | 2020-03-16 | 75,000 | — | $0 | 75,000 | SEC↗ |
| 667, L.P. | Director | A Award deriv | 2019-12-20 | 2019-12-20 | 9,765,333 | — | $0 | 9,765,333 | SEC↗ |
| 667, L.P. | Director | A Award deriv | 2019-12-20 | 2019-12-20 | 1,160,148 | — | $0 | 1,161,048 | SEC↗ |
| 667, L.P. | Director | P Buy | 2019-12-20 | 2019-12-20 | 2,767,505 | $8.40 | $23.25M | 12,872,664 | SEC↗ |
| 667, L.P. | Director | D To issuer | 2019-12-20 | 2019-12-20 | 1,160,148 | — | $0 | 290,409 | SEC↗ |
| 667, L.P. | Director | D To issuer | 2019-12-20 | 2019-12-20 | 9,765,333 | — | $0 | 3,107,331 | SEC↗ |
| 667, L.P. | Director | P Buy | 2019-12-20 | 2019-12-20 | 250,037 | $8.40 | $2.10M | 1,450,557 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | P Buy | 2019-12-20 | 2019-12-20 | 119,047 | $8.40 | $1000.0K | 2,198,686 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | C Conversion | 2019-11-12 | 2019-12-20 | 12,616 | — | $0 | 0 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | C Conversion | 2019-11-12 | 2019-12-20 | 1,261,600 | — | $0 | 2,079,639 | SEC↗ |
| Williams Lewis T | Director | A Award deriv | 2019-10-10 | 2019-10-15 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Nolan Sean P. | Director | A Award deriv | 2019-10-10 | 2019-10-15 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Noonberg Sarah B. | Director | A Award deriv | 2019-10-10 | 2019-10-15 | 22,000 | — | $0 | 22,000 | SEC↗ |
| SIMPSON TODD E | Director | A Award deriv | 2019-10-10 | 2019-10-15 | 22,000 | — | $0 | 22,000 | SEC↗ |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | A Award deriv | 2019-10-10 | 2019-10-15 | 22,000 | — | $0 | 22,000 | SEC↗ |
| DRACHMAN JONATHAN G | See Remarks | P Buy | 2019-09-11 | 2019-09-11 | 136,436 | $3.30 | $450.2K | 584,428 | SEC↗ |
| DRACHMAN JONATHAN G | See Remarks | P Buy | 2019-09-10 | 2019-09-11 | 36,742 | $3.08 | $113.2K | 447,992 | SEC↗ |
| DRACHMAN JONATHAN G | See Remarks | P Buy | 2019-09-09 | 2019-09-11 | 76,822 | $2.85 | $218.9K | 411,250 | SEC↗ |
| DRACHMAN JONATHAN G | See Remarks | A Award deriv | 2019-08-31 | 2019-09-04 | 1,650,000 | — | $0 | 1,650,000 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | A Award | 2019-08-08 | 2019-08-12 | 7,428 | — | $0 | 7,428 | SEC↗ |
| DRACHMAN JONATHAN G | President and CEO | A Award | 2019-08-08 | 2019-08-12 | 334,428 | — | $0 | 334,428 | SEC↗ |
| DRACHMAN JONATHAN G | See Remarks | A Award | 2019-08-08 | 2019-09-13 | 568,039 | — | $0 | 568,039 | SEC↗ |
| DRACHMAN JONATHAN G | See Remarks | A Award | 2019-08-08 | 2019-09-13 | 12,616 | — | $0 | 12,616 | SEC↗ |
| BREWER RICHARD B | Executive Chairman | P Buy deriv | 2012-03-30 | 2012-04-02 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Kazam Joshua A | President & CEO | P Buy deriv | 2012-03-30 | 2012-04-02 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Lieu Hsiao | Executive VP, Clinical Dev. | P Buy deriv | 2012-03-30 | 2012-04-02 | 9,375 | — | $0 | 9,375 | SEC↗ |
| Evans Daron | Chief Financial Officer | P Buy deriv | 2012-03-30 | 2012-04-02 | 9,375 | — | $0 | 9,375 | SEC↗ |
| BREWER RICHARD B | Executive Chairman | P Buy | 2012-03-30 | 2012-04-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Kazam Joshua A | President & CEO | P Buy | 2012-03-30 | 2012-04-02 | 125,000 | — | $0 | 1,453,228 | SEC↗ |
| Lieu Hsiao | Executive VP, Clinical Dev. | P Buy | 2012-03-30 | 2012-04-02 | 12,500 | — | $0 | 12,600 | SEC↗ |
| Evans Daron | Chief Financial Officer | P Buy | 2012-03-30 | 2012-04-02 | 12,500 | — | $0 | 25,652 | SEC↗ |